Zydus Lifesciences Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 5/6

Zydus Lifesciences verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 19%, während die Gewinne der Branche Pharmaceuticals jährlich um gewachsen und zwar um 13.6%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 7.5%. Die Eigenkapitalrendite von Zydus Lifesciences beträgt 19.4% und die Nettomargen betragen 20.2%.

Wichtige Informationen

19.0%

Wachstumsrate der Gewinne

19.3%

EPS-Wachstumsrate

Pharmaceuticals Wachstum der Industrie17.5%
Wachstumsrate der Einnahmen7.5%
Eigenkapitalrendite19.4%
Netto-Marge20.2%
Nächste Ertragsaktualisierung12 Nov 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Here's Why We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Is Well Worth Watching

Sep 14
Here's Why We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Is Well Worth Watching

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Business And Shares Still Trailing The Market

Aug 30
Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Business And Shares Still Trailing The Market

Zydus Lifesciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 14
Zydus Lifesciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment

Aug 03
Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Jul 19
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 05
Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Jun 20
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

May 25
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?

Mar 18
Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?

Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%

Feb 28
Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%

Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report

Feb 12
Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report

Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Dec 27
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors

Dec 06
Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors

With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case

Aug 23
With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case

Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

Jul 17
Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Jul 15
We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's

Jun 24
Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's

Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00

Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00

Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

May 21
Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

Feb 15
Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Nov 13
We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Aufschlüsselung der Einnahmen und Ausgaben

Wie Zydus Lifesciences Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

NSEI:ZYDUSLIFE Einnahmen, Ausgaben und Erträge (INR Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Jun 24206,15341,68543,9880
31 Mar 24195,47438,36542,4570
31 Dec 23190,24129,56240,2380
30 Sep 23187,76028,10938,9550
30 Jun 23184,12725,26238,1430
31 Mar 23172,37419,64937,6490
31 Dec 22164,33520,78534,5720
30 Sep 22157,11019,62933,5940
30 Jun 22153,36121,71033,0720
31 Mar 22151,09922,41632,4980
31 Dec 21157,60923,26733,8690
30 Sep 21157,38923,26934,1550
30 Jun 21156,13022,60033,7160
31 Mar 21144,03522,01631,2500
31 Dec 20150,07618,46533,8820
30 Sep 20148,50116,93233,7380
30 Jun 20143,96713,27033,5500
31 Mar 20142,53111,76633,0800
31 Dec 19142,33812,44830,6520
30 Sep 19141,73613,81629,7020
30 Jun 19137,68216,91928,9470
31 Mar 19131,65618,48828,3150
31 Dec 18126,70619,95426,9620
30 Sep 18123,52620,30526,3770
30 Jun 18126,13321,16825,8010
31 Mar 18119,04917,94624,8740
31 Dec 17111,69115,70523,0760
30 Sep 17102,20613,51122,1780
30 Jun 1793,39712,27715,7180
31 Mar 1793,76514,90420,7740
31 Dec 1697,49411,32322,8400
30 Sep 1697,97112,81222,1100
30 Jun 1697,22114,18613,8630
31 Mar 1694,26819,33919,8750
31 Dec 1595,90114,84326,7490
30 Sep 1592,45313,76626,7440
30 Jun 1589,79512,63826,2770
31 Mar 1586,51311,50619,0600
31 Dec 1482,95510,39424,7400
30 Sep 1479,7779,43524,1840
30 Jun 1476,1658,48824,0410
31 Mar 1472,0348,03623,7710
31 Dec 1368,2048,26621,5950

Qualität der Erträge: ZYDUSLIFE hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: ZYDUSLIFEDie aktuellen Gewinnspannen (20.2%) sind höher als im letzten Jahr (13.7%).


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: ZYDUSLIFEIn den letzten 5 Jahren sind die Gewinne von 19% jährlich gestiegen.

Beschleunigtes Wachstum: ZYDUSLIFEDas Gewinnwachstum des Unternehmens im letzten Jahr (65%) übertrifft seinen 5-Jahres-Durchschnitt (19% pro Jahr).

Erträge im Vergleich zur Industrie: ZYDUSLIFE Das Gewinnwachstum im vergangenen Jahr (65%) übertraf das der Branche Pharmaceuticals 19.1% .


Eigenkapitalrendite

Hohe Eigenkapitalrendite: ZYDUSLIFEDie Eigenkapitalrendite des Unternehmens (19.4%) wird als niedrig angesehen.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren